Does preserved DHT with low estradiol suggest a selective estrogen-signaling deficit?

In postmenopausal physiology, the transition of ovarian function leads to a profound drop in circulating estradiol. However, this localized ovarian decline does not represent a systemic shutdown of the entire endocrine axis.

Clinical and endocrine profiling

• Divergent hormone profiles: Ovarian failure causes a sharp decline in estradiol, typically to menopausal ranges (<20 pg/mL), but this does not dictate a global depletion of all sex steroids.
• Preservation of androgenic signaling: Clinical assessments often reveal relatively preserved or mid-range dihydrotestosterone (DHT) levels despite low estradiol, demonstrating that broad androgenic signaling pathways remain viable.

Mechanistic pathways of hormone preservation

• Continued adrenal activity: While ovarian estrogen synthesis ceases, adrenal production of androgens—specifically dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and androstenedione—persists.
• Peripheral conversion pathways: These adrenal precursors undergo peripheral conversion into testosterone, which is subsequently synthesized into DHT via the 5-alpha reductase enzyme. Because DHT is a potent, non-aromatizable androgen, its maintenance confirms that the biochemical machinery for androgenic synthesis remains fully operational.

Bottom line

• Preserved DHT levels alongside low estradiol indicate that adrenal-derived androgenic pathways and peripheral steroid conversions remain active, confirming a selective estrogen-signaling deficit rather than a global collapse of sex-hormone activity.